2.87
+0.09(+3.24%)
Currency In USD
| Previous Close | 2.78 |
| Open | 2.75 |
| Day High | 2.87 |
| Day Low | 2.75 |
| 52-Week High | 107.94 |
| 52-Week Low | 2.6 |
| Volume | 28,042 |
| Average Volume | 216,217 |
| Market Cap | 2.59M |
| PE | -0.01 |
| EPS | -313.92 |
| Moving Average 50 Days | 3.66 |
| Moving Average 200 Days | 24.1 |
| Change | 0.09 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of November 10, 2025 at a share price of $2.87. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0 as of November 10, 2025 at a share price of $2.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
GlobeNewswire Inc.
Oct 23, 2025 1:00 PM GMT
MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys,
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
GlobeNewswire Inc.
Sep 30, 2025 12:45 PM GMT
ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediatric care an
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
GlobeNewswire Inc.
Sep 18, 2025 1:00 PM GMT
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application